XZXiaowei Zhang

Xiaowei Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaowei Zhang has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficient generation of epitope-targeted de novo antibodies with Germinal

    by Luis S. Mille-Fragoso, Claudia L. Driscoll, John N. Wang, Haoyu Dai, Talal Widatalla, Jim L. Zhang, Xiaowei Zhang, Bing Rao, Liang Feng, Brian L. Hie, et al.

    Obtaining novel antibodies against specific protein targets is a widely important yet experimentally laborious process. Meanwhile, computational methods for antibody design have been limited by low success rates that currently require resource-intensive screening. Here, we introduce Germinal, a broadly enabling generative pipeline that designs antibodies against specific epitopes with nanomolar binding affinities while requiring only low-n experimental testing. Our method co-optimizes antibody structure and sequence by integrating a structure predictor with an antibody-specific protein language model to perform de novo design of functional complementarity-determining regions (CDRs) onto a user-specified structural framework. When tested against four diverse protein targets, Germinal successfully designed functional antibodies across all targets and binder formats, testing only 43-101 designs for each antigen. Validated designs also exhibited robust expression in mammalian cells and high sequence and structural novelty. We provide open-source code and full computational and experimental protocols to facilitate wide adoption. Germinal represents a milestone in efficient, epitope-targeted de novo antibody design, with notable implications for the development of molecular tools and therapeutics.


  • Open Access

    Generative steering to adapt proteins beyond native biological contexts

    by Xiaowei Zhang, Wenhui Sophia Lu, Ben Viggiano, Kevin Reynolds, Sophia Burick, Elena Sotillo, Haoyu Dai, Geonhu Lee, Zixuan Liu, Nuoya Yang, et al.

    Proteins evolved for native biological contexts often fail when deployed in new cellular environments or therapeutic settings. We present ProVADA, a test-time framework that steers a pretrained protein generator toward externally defined properties while preserving functional constraints. Its Mixture-Adaptation Directed Annealing sampler combines coordinated mutations, population selection, and annealing to navigate rugged objective landscapes. Experimentally, ProVADA converted secreted human renin into an active, drug-inhibitable cytosolic protease and extensively deimmunized two murine single-chain antibody fragments to reduce HLA visibility while retaining antigen recognition. ESCAPE-seq measurements confirmed substantial depletion of HLA-I binder peptides across alleles. Deimmunized FMC63 variants retained CAR-T-cell killing and showed fewer binders than a tested humanized comparator. Together, these results demonstrate that broad sequence redesign can adapt functional proteins to non-native biological contexts.


  • Post-transcriptional modular synthetic receptors

    by Xiaowei Zhang, Luis S. Mille-Fragoso, K. Eerik Kaseniit, Arden P. Lee, Meng Zhang, Connor C. Call, Yixin Hu, Yunxin Xie, Xiaojing J. Gao

    Inspired by the power of transcriptional synthetic receptors and hoping to complement them to expand the toolbox for cell engineering, we establish LIDAR (Ligand-Induced Dimerization-Activating RNA editing), a modular post-transcriptional synthetic receptor platform that harnesses RNA editing by adenosine deaminases acting on RNA. LIDAR is compatible with various receptor architectures in different cellular contexts and enables the sensing of diverse ligands and the production of functional outputs. Furthermore, LIDAR can sense orthogonal signals in the same cell and produce synthetic spatial patterns, potentially enabling the programming of complex multicellular behaviors. Lastly, LIDAR is compatible with compact encoding and can be delivered as synthetic mRNA. Thus, LIDAR expands the family of synthetic receptors, holding the promise to empower basic research and therapeutic applications.


  • Open Access

    Post-Transcriptional Modular Synthetic Receptors

    by Xiaowei Zhang, Luis S. Mille-Fragoso, K. Eerik Kaseniit, Connor C. Call, Meng Zhang, Yixin Hu, Yunxin Xie, Xiaojing J. Gao

    Inspired by the power of transcriptional synthetic receptors and hoping to complement them to expand the toolbox for cell engineering, we establish LIDAR (Ligand-Induced Dimerization Activating RNA editing), a modular post-transcriptional synthetic receptor platform that harnesses RNA editing by ADAR. LIDAR is compatible with various receptor architectures in different cellular contexts, and enables the sensing of diverse ligands and the production of functional outputs. Furthermore, LIDAR can sense orthogonal signals in the same cell and produce synthetic spatial patterns, potentially enabling the programming of complex multicellular behaviors. Finally, LIDAR is compatible with compact encoding and can be delivered as synthetic mRNA. Thus, LIDAR expands the family of synthetic receptors, holding the promise to empower basic research and therapeutic applications.


  • Open Access

    Sensitive bacterial V m sensors revealed the excitability of bacterial V m and its role in antibiotic tolerance

    by Xin Jin, Xiaowei Zhang, Xuejing Ding, Tian Tian, Chao-Kai Tseng, Xinwei Luo, Xiao Chen, Chien-Jung Lo, Mark C. Leake, Fan Bai

    As an important free energy source, the membrane voltage (V m ) regulates many essential physiological processes in bacteria. However, in comparison with eukaryotic cells, knowledge of bacterial electrophysiology is very limited. Here, we developed a set of novel genetically encoded bacterial V m sensors which allow single-cell recording of bacterial V m dynamics in live cells with high temporal resolution. Using these new sensors, we reveal the electrically “excitable” and “resting” states of bacterial cells dependent on their metabolic status. In the electrically excitable state, frequent hyperpolarization spikes in bacterial V m are observed, which are regulated by Na + /K + ratio of the medium and facilitate increased antibiotic tolerance. In the electrically resting state, bacterial V m displays significant cell-to-cell heterogeneity and is linked to the cell fate after antibiotic treatment. Our findings demonstrate the potential of our newly developed voltage sensors to reveal the underpinning connections between bacterial V m and antibiotic tolerance.


  • Multiplexed genome regulation in vivo with hyper-efficient Cas12a

    by Lucie Y. Guo, Jing Bian, Alexander E. Davis, Pingting Liu, Hannah R. Kempton, Xiaowei Zhang, Augustine Chemparathy, Baokun Gu, Xueqiu Lin, Draven A. Rane, et al.

    Multiplexed modulation of endogenous genes is crucial for sophisticated gene therapy and cell engineering. CRISPR–Cas12a systems enable versatile multiple-genomic-loci targeting by processing numerous CRISPR RNAs (crRNAs) from a single transcript; however, their low efficiency has hindered in vivo applications. Through structure-guided protein engineering, we developed a hyper-efficient Lachnospiraceae bacterium Cas12a variant, termed hyperCas12a, with its catalytically dead version hyperdCas12a showing significantly enhanced efficacy for gene activation, particularly at low concentrations of crRNA. We demonstrate that hyperdCas12a has comparable off-target effects compared with the wild-type system and exhibits enhanced activity for gene editing and repression. Delivery of the hyperdCas12a activator and a single crRNA array simultaneously activating the endogenous Oct4, Sox2 and Klf4 genes in the retina of post-natal mice alters the differentiation of retinal progenitor cells. The hyperCas12a system offers a versatile in vivo tool for a broad range of gene-modulation and gene-therapy applications.